Life ScienceCompany
Kite Pharma M&A Summary
Kite Pharma has acquired 3 companies of its own, including 1 in the last 5 years. It has also divested 1 asset.
Kite Pharma’s largest acquisition to date was in 2017, when it acquired Cell Design Labs for $567M. Kite Pharma has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).
Kite Pharma Ownership
Who owns Kite Pharma?
Kite Pharma is owned by Gilead Sciences. It was acquired on August 28, 2017.
Was Kite Pharma formerly PE-backed?
Yes. Kite Pharma was formerly owned by 1 private investor.
Kite Pharma Business Overview
Where is Kite Pharma headquartered?
Kite Pharma is headquartered in Santa Monica, California.
What is Kite Pharma’s revenue?
Kite Pharma disclosed revenue of 22M USD for 2016 and 17M USD for 2015.
How many employees does Kite Pharma have?
Kite Pharma has 184 employees.
What sector is Kite Pharma in?
Kite Pharma is a life science company.
When was Kite Pharma founded?
Kite Pharma was founded in 2009.
M&A Summary
-
M&A Total Activity4
- M&A Buy Activity3
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 2
- M&A Buy/Sell Connections 2
- M&A Advisors 1